South Korea’s Ministry of Food and Drug Safety (MFDS) will introduce this year a new regulatory program called “Guide” which plans to initially select 20 innovative products, including novel drugs, medical devices and cutting-edge biologics, for rapid shepherding to the approval stage through focused and continued consultations with regulatory authorities.
Korea ‘Guide’ Program To Speed Select Innovative Products To Market
Part Of Regulatory Science Push
In an ongoing effort to accelerate the commercialization of select innovative drugs and medical devices, Korea’s MFDS is launching a new program for certain products that will receive regular regulatory consultations until they reach the approval stage.
